公司百科
檢視更多
name
Lifevantage
LFVN.US
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants.
5145 億
LFVN.US總市值 -市值排名 -/-

財務評分

31/12/2025 更新
B
個人護理產品產品行業
同行業排名14/55
行業中位數C
行業平均值C
評分分析
同行比較
  • 指標
    評分
  • 盈利評分A
    • 凈資產收益率(ROE)33.31%A
    • 凈利率4.43%C
    • 毛利率79.51%A
  • 成長評分B
    • 營業收入同比16.77%B
    • 凈利潤同比145.14%A
    • 總資產同比0.19%C
    • 凈資產同比19.71%A
  • 現金評分B
    • 現金流凈利率2258.51%A
    • 運營現金流同比16.77%B
  • 運營評分A
    • 資產周轉率3.72A
  • 負債評分C
    • 資產負債率46.16%C

估值分析

portai
市盈率
1年
3年
5年
10年
市盈率
-
同行業排名
-/-
  • 市盈率
  • 成本
  • 高分位
  • 中位數
  • 低分位
市淨率
1年
3年
5年
10年
市淨率
-
同行業排名
-/-
  • 市淨率
  • 成本
  • 高分位
  • 中位數
  • 低分位
市銷率
1年
3年
5年
10年
市銷率
-
同行業排名
-/-
  • 市銷率
  • 成本
  • 高分位
  • 中位數
  • 低分位
股息率
1年
3年
5年
10年
股息率
-
同行業排名
-/-
  • 股息率
  • 成本
  • 高分位
  • 中位數
  • 低分位

機構觀點 & 持股股東

分析師評級

評級
佔比
    • 股價
      --
    • 預測最高價
      --
    • 預測最低價
      --
    資訊
    檢視更多